These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11160768)

  • 1. Advances in the treatment of lupus nephritis.
    Zimmerman R; Radhakrishnan J; Valeri A; Appel G
    Annu Rev Med; 2001; 52():63-78. PubMed ID: 11160768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide.
    Daikh DI; Wofsy D
    J Immunol; 2001 Mar; 166(5):2913-6. PubMed ID: 11207238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lupus nephritis: treatments for today and tomorrow].
    de Frutos MA
    Nefrologia; 2001; 21(6):522-3. PubMed ID: 11881420
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials in lupus nephritis.
    Ginzler EM
    Curr Rheumatol Rep; 2001 Jun; 3(3):199-204. PubMed ID: 11352788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies in lupus - focus on nephritis.
    Cordeiro AC; Isenberg DA
    Acta Reumatol Port; 2008; 33(2):157-69. PubMed ID: 18604181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways.
    Daikh DI; Finck BK; Linsley PS; Hollenbaugh D; Wofsy D
    J Immunol; 1997 Oct; 159(7):3104-8. PubMed ID: 9317105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New prospects for treatment of lupus nephritis.
    Balow JE; Boumpas DT; Austin HA
    Semin Nephrol; 2000 Jan; 20(1):32-9. PubMed ID: 10651216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins.
    Arahata H; Migita K; Izumoto H; Miyashita T; Munakata H; Nakamura H; Tominaga M; Origuchi T; Kawabe Y; Hida A; Taguchi T; Eguchi K
    Clin Rheumatol; 1999; 18(1):77-81. PubMed ID: 10088959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic.
    Ripoll È; Merino A; Grinyó JM; Torras J
    Immunotherapy; 2013 Oct; 5(10):1089-101. PubMed ID: 24088078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
    Mihara M; Tan I; Chuzhin Y; Reddy B; Budhai L; Holzer A; Gu Y; Davidson A
    J Clin Invest; 2000 Jul; 106(1):91-101. PubMed ID: 10880052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies in lupus nephritis.
    Tahir H; Isenberg DA
    Lupus; 2005; 14(1):77-82. PubMed ID: 15732293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus.
    Morimoto S; Watanabe T; Lee S; Amano H; Kanamaru Y; Ohsawa I; Tomino Y; Takasaki Y
    Mod Rheumatol; 2010 Jun; 20(3):291-4. PubMed ID: 20082110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-directed therapies in systemic lupus erythematosus.
    Nandkumar P; Furie R
    Lupus; 2016 Sep; 25(10):1080-5. PubMed ID: 27497252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG.
    Silvestris F; D'Amore O; Cafforio P; Savino L; Dammacco F
    Clin Exp Immunol; 1996 May; 104 Suppl 1():91-7. PubMed ID: 8625551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.
    Carroll RP; Brown F; Kerr PG
    Nephrol Dial Transplant; 2007 Jan; 22(1):291-3. PubMed ID: 17095581
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of systemic lupus proliferative nephritis.
    Punaro MG
    Pediatr Nephrol; 2013 Nov; 28(11):2069-78. PubMed ID: 23179192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.